|
Rating: 
List Price: $29.99
Sale Price: $399.99
Availability: unspecified
|
Product Description
The MotherVine Nutraceutical Company is inspired by the oldest living grapevine in America, The MotherVine, circa 1584. We are the premier provider of natural and organic products from the Muscadine Vine and Honey Bee Hive. Made in the USA and following cGMP standards, our dietary supplements feature Whole Muscadine Grapes, one of nature's richest sources of polyphenolic antioxidants*, which research suggests strengthens the body and builds a healthy immune system. *The Journal of Agricultural and Food Chemistry 51(18):5497-503)
Details
- 24 bottles of 60 capsules each containing Whole Muscadine Grapes - Seeds, Pulp and Skins, TWO Bottles Sent Monthly
- Made in the USA under highest quality conditions (cGMP facility)
- Supports a healthy immune system through whole food nutrition
- 88 different phytonutrients have been identified in Muscadines
- Price includes shipping and handling
Black patients suffering from lung cancer are less likely to receive recommended chemotherapy and surgery than white lung cancer patients, a disparity that shows no signs of lessening. That is the conclusion of a new study published in the May 15, 2009 issue of CANCER, a peer-reviewed journal of the American Cancer Society. The study’s findings indicate that efforts are needed to provide appropriate treatments for black patients and to educate them about the value of those treatments. Researchers led by Dale Hardy, Ph.D., of the University of Texas School of Public Health analyzed data from 83,101 patients 65 years old or older who were diagnosed with non-small cell lung cancer, the most common type of lung cancer, between 1991 and 2002….
Women with mental disorders are less likely to have screening mammograms than women without mental illness, although. the nature of the mental illness does play a role, as per a large study published by Indiana University School of Medicine and Richard Roudebush VA Health Services Center for Excellence scientists in the recent issue of Journal of General Internal Medicine. Previous to this study, little was known about whether the type or severity of mental illness influences receipt of preventive services such as mammograms……..
Background:
A phase III multi-centre randomised trial (ROSEL) has been initiated to establish the role of stereotactic radiotherapy in patients with operable stage IA lung cancer. Due to rapid changes in radiotherapy technology and evolving techniques for image-guided delivery, guidelines had to be developed in order to ensure uniformity in implementation of stereotactic radiotherapy in this multi-centre study.
Methods:
A Quality Assurance Working Party was formed by radiation oncologists and clinical physicists from both academic as well as non-academic hospitals that had already implemented stereotactic radiotherapy for lung cancer. A literature survey was conducted and consensus meetings were held in which both the knowledge from the literature and clinical experience were pooled. In addition, a planning study was performed in 26 stage I patients, of which 22 were stage 1A, in order to develop and evaluate the planning guidelines. Plans were optimised according to parameters adopted from RTOG trials using both an algorithm with a simple homogeneity correction (Type A) and a more advanced algorithm (Type B) . Dose conformity requirements were then formulated based on these results.
Conclusions:
Based on current literature and expert experience, guidelines were formulated for this phase III study of stereotactic radiotherapy versus surgery. These guidelines can serve to facilitate the design of future multi-centre clinical trials of stereotactic radiotherapy in other patient groups and aid a more uniform implementation of this technique outside clinical trials.
ALAMEDA, Calif. — Celera Corporation today announced the presentation of data describing a novel mass spectrometry-based approach to identify and validate circulating protein biomarkers that detect non-small cell lung cancer (NSCLC). A key outcome of the study was the assembly of an immunoassay test for a panel of 6 biomarkers that detected lung cancer with 94% sensitivity and 93% specificity in a blinded analysis. In addition to detecting all stages of lung cancer studied and all major histological subtypes, the panel also accurately distinguished malignant cases from benign lung disease. The data will be presented from 8:00 a.m. to 12:00 p.m. MDT today as poster #3542 at the 100th Annual American Association for Cancer…
Elderly breast cancer patients who received care in a community hospital setting may have been under-diagnosed, under-staged and under-treated, as per a report in the recent issue of Archives of Surgery, one of the JAMA/Archives journals. The number of older patients with breast cancer has increased along with overall elderly population, as per background information in the article. About half of patients with breast cancer are older than 65 years and 35 percent are older than 70; 77 percent of breast cancer deaths occur in women older than 55. Choosing the appropriate therapy for older patients is a challenge, because a number of have other serious illnesses in addition to their cancer that may threaten their health and shorten their lives. Questions remain about the best screening protocols for elderly women, as well. Some current guidelines suggest that women stop having mammograms at age 70, while others provide no upper limit……..
MRI is better than MDCT for determining if and how far breast cancer has spread into the breast ducts and should be used before patients receive breast conserving treatment, a new study shows. “Patients have a lower survival rate if their surgical margins are positive for tumor cells. A positive surgical margin is commonly the result of inadequate resection of the cancer’s intraductal component,” said Akiko Shimauchi, MD, at Tohoku University in Sendai, Miyagi, Japan. “Accurate preoperative diagnosis of the intraductal component allows the surgeon to achieve a cancer-free surgical margin,” she said……..
A nicotine compound called NNAL appears to be a bellwether for smokers of their risk of lung cancer, according to new University of Minnesota research results. Evaluating urine samples from 491 smokers, U tobacco researcher Jian-Min Yuan found that high levels of NNAL doubled the risk of lung cancer. Even moderate levels of the compound increased the cancer risk among the smokers by 43 percent. “We’ve known for a long time that smoking increases a person’s risk for getting lung cancer, but we have not been able to clearly answer why one smoker would eventually develop lung cancer and another one would not,” Yuan said. “Now we know one definitive link.” The results were presented Sunday at a national cancer research convention and p…
MRI is better than MDCT for determining if and how far breast cancer has spread into the breast ducts and should be used before patients receive breast conserving treatment, a new study shows. “Patients have a lower survival rate if their surgical margins are positive for tumor cells. A positive surgical margin is commonly the result of inadequate resection of the cancer’s intraductal component,” said Akiko Shimauchi, MD, at Tohoku University in Sendai, Miyagi, Japan. “Accurate preoperative diagnosis of the intraductal component allows the surgeon to achieve a cancer-free surgical margin,” she said……..
Malignant Melanoma can be cured in 95% of cases if detected early (this is what I have been told). That last part is the real kicker. EARLY!
Products, The MotherVine Nutraceutical Company | admin January 21, 2012 | 
Comments (0) 